The Recall Desk
ModerateFDA (Drugs)·D-0321-2025·Announced 2025-04-16

Lacosamide Tablets 200mg Recalled Due to CGMP Deviations

Glenmark Pharmaceuticals is recalling Lacosamide Tablets 200mg nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall is voluntary and affects specific lot numbers with expiration dates ranging from April 2025 to April 2026.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall for CGMP deviations, which are manufacturing defects. The source text does not report any illnesses, injuries, or clinical consequences, making this a precautionary/low-risk contamination scenario rather than a confirmed hazard recall.

Plain-English summary

Glenmark Pharmaceuticals Inc., USA is recalling Lacosamide Tablets 200mg, 60-count bottles nationwide. The recall was initiated on March 13, 2025, due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing.

The affected product is Lacosamide (generic name) Tablets 200mg, NDC# 68462-681-60, manufactured by Glenmark Pharmaceuticals Limited in Pithampur, Madhya Pradesh, India, and manufactured for Glenmark Pharmaceuticals Inc. USA in Mahwah, NJ. Eight specific lot numbers are affected: 17230982, 17230986, 17231001, 17240197, 17240198, 17240215, 17240846, and 17240847, with expiration dates ranging from April 2025 to April 2026.

This is a voluntary, firm-initiated recall. Lacosamide is a prescription antiepileptic drug. Patients currently taking affected lots should consult their healthcare provider or pharmacist regarding the recall. The FDA classified this as a Class II recall on April 8, 2025.

The recalled product

Product
LACOSAMIDE (LACOSAMIDE)
Brand
LACOSAMIDE
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Category
Drug — Antiepileptic Tablets
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (10)

  • Lot # 17230982
  • exp. date Apr-25 17230986
  • exp. date
  • Apr-25 17231001
  • Apr-25 17240197
  • exp. date Jan-26 17240198
  • exp. date Jan-26 17240215
  • exp. date Jan-26 17240846
  • exp. date Apr-26 17240847
  • exp. date Apr-26

UPCs (4)

  • 0368462681602
  • 0368462679609
  • 0368462678602
  • 0368462680605

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 39 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 39 products in this recall →

Related recalls

Same brand · LACOSAMIDE

Same manufacturer · Glenmark Pharmaceuticals Inc., USA

See all →

Same hazard · cgmp deviation

See all →